Nonalcoholic fatty liver disease (NAFLD) is an epidemic liver disease, affecting
approximately one quarter of the entire population in the world.(1) This disease …

Whereas in most cases a fatty liver remains free of inflammation, 10%‐20% of patients who
have fatty liver develop inflammation and fibrosis (nonalcoholic steatohepatitis [NASH]) …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world, and it comprises a spectrum of hepatic abnormalities from simple hepatic steatosis to …

Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease but the
second cause of death among NAFLD patients are attributed to malignancies at both …

Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing
challenge in terms of prevention and treatment. Despite its high prevalence, only a small …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common comorbidities
associated with overweight and metabolic syndrome (MetS). Importantly, NAFLD is one of its …

Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease in the United States. 1–3 It has been broadly subdivided into 2 categories including …

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …

(MS), is a complex trait resulting from the interaction between multiple genes and social,
behavioral, and environmental factors. Steatosis, the histological hallmark of NAFLD, is …